GLOBALCAPITAL INTERNATIONAL LIMITED, a company

incorporated in England and Wales (company number 15236213),

having its registered office at 4 Bouverie Street, London, UK, EC4Y 8AX

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

AXIS bank

  • A dual currency financing to back Indian company Intas Pharmaceuticals’ acquisition of a portfolio of assets in the UK and Ireland has netted $650m-$670m of commitments.
  • Few Indian IPOs can boast of having $6.4bn in excess demand, but BSE is one of them. The Bombay stock exchange operator completed bookbuilding for its Rp12.4bn ($182m) float this week, an extraordinary end to a sale first mooted over a decade ago. The pressure is now on its larger rival to do just as well, writes John Loh.
  • India’s BSE could not have wished for a sweeter end to its Rp12.4bn ($182m) IPO, which on Wednesday closed hugely oversubscribed.
  • BSE, the owner of the Bombay Stock Exchange, is off to a cork-popping start to its Rp12.4bn ($182m) IPO, having snagged both marquee anchor investors and strong early orders.
  • The Bombay Stock Exchange has announced a marketing range for its long-awaited IPO in India, leaving no doubt that the Rp12.4bn ($182m) deal will price at the top of expectations.
  • A dual currency financing to back Indian company Intas Pharmaceuticals’ acquisition of a portfolio of assets in the UK and Ireland has attracted subscriptions totalling $350m, with banks given another week to commit.
  • Indian power company NTPC and Malaysia’s Genting Overseas Holding Company are planning their respective debut outings, with the former seeking euros and the latter dollars.
  • A group of seven lenders opened a $600m loan for State Bank of India to retail participation this week, with three tickets up for grabs.
  • Invitations are out for a $1.8bn Asian loan that will refinance a US term loan B for Novelis. The launch comes about a month after the firm mandated 10 lenders to arrange the borrowing.
  • Robust demand is expected to result in an oversubscription for a dual currency financing to back Indian company Intas Pharmaceuticals’ acquisition of a portfolio of assets in the UK and Ireland.
  • School textbook publisher S Chand and Co has submitted a listing application to the Indian regulator, offering new as well as secondary equity.
  • Indian conglomerate Reliance Group is the latest to file for an infrastructure investment trust listing, announcing plans to raise Rp30bn ($442m).